Skip to main content

Day: August 16, 2021

Cellectar Announces Manufacturing and Supply Agreement with Evergreen Theragnostics for CLR-131, now known as iopofosine I-131

Evergreen to provide clinical and commercial supply of iopofosine I-131 (also known as CLR 131) Agreement adds second manufacturer and expands Cellectar’s current supply capabilities FLORHAM PARK, N.J., Aug. 16, 2021 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that it has entered into a commercial manufacturing and supply agreement with Evergreen Theragnostics, a global radiopharmaceutical contract development and manufacturing organization (CDMO) based in Springfield, NJ. The company also announced that the United States Adopted Names Council (USAN) has approved the use of “iopofosine I-131” as the generic name for CLR-131. The agreement with Evergreen provides long term...

Continue reading

Skillful Craftsman Announces Director Change

WUXI, China, Aug. 16, 2021 (GLOBE NEWSWIRE) — Skillful Craftsman Education Technology Ltd. (“the Company” or “Skillful Craftsman”) (NASDAQ: EDTK), an education technology company providing interactive online learning services, today announced that its board of directors (the “Board”) has appointed Mr. Shaowei Zhang as a new independent director of the Board to succeed Mr. Limin Huang, who has resigned on August 13, 2021. Mr. Shaowei Zhang is the founder of First High-School Education Group Co., Ltd (“First High-School Education”) (NYSE: FHS). Mr. Zhang has served as the chairman of board of directors and chief executive officer of First High-School Education since September 2018. Prior to founding First High-School Education, Mr. Zhang established and served as the principal of Kunming Qihang Education and Training...

Continue reading

FenixOro Gold Corp Now Available for Trading on Wealthsimple

TORONTO, Aug. 16, 2021 (GLOBE NEWSWIRE) — FenixOro Gold Corp (CSE:FENX, OTC:FDVXF, Frankfurt:8FD) is pleased to announce that the common shares of the Company have been listed for trading on the Wealthsimple platform. With offices in Toronto, New York, and London, Wealthsimple aims to provide smart, simple investing, without the high fees and account minimums associated with traditional investment management. The stock trading platform features commission-free trading with no account minimums and allows investors to buy and sell thousands of stocks and ETFs on major Canadian and US exchanges. It is Canada’s only platform providing trading for fractional Canadian and US stocks. The Board and management of FenixOro are pleased that more investors will now have the ability and access to invest in the Company’s efforts to develop its...

Continue reading

GLOBAL TECH INDUSTRIES GROUP, INC. LAUNCHES BEYOND BLOCKCHAIN APP ON APPLE APP STORE

New York, NY, Aug. 16, 2021 (GLOBE NEWSWIRE) — (GTII:OTCQB) Global Tech Industries Group, Inc. (OTCQB: GTII) (“GTII” or the “Company”), www.gtii-us.com, a Nevada corporation, announced today that its new iOS App, Beyond Blockchain: Buy Crypto, has launched and is available for download on the Apple App Store. The app is the mobile version of the BeyondBlockchain.us website and will enable mobile traders to enjoy all the security and features of their BeyondBlockchain.us accounts on the go. The Beyond Blockchain: Buy Crypto app gives registered users 24 hours/7 days-a -week access to their accounts and the trading platform. It allows them to trade the top cryptocurrencies like Bitcoin (BTC), Ethereum (ETH), Chainlink (LINK) and other tokens. Similar to the web-based platform, this app allows trading against multiple Fiat and Crypto...

Continue reading

EHang to Report First and Second Quarter 2021 Unaudited Financial Results on Wednesday, August 25, 2021

GUANGZHOU, China, Aug. 16, 2021 (GLOBE NEWSWIRE) — EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading autonomous aerial vehicle (“AAV”) technology platform company, today announced that it will release its unaudited financial results for the first quarter ended March 31, 2021 and the second quarter ended June 30, 2021 on Wednesday, August 25, 2021, before the U.S. market opens. EHang’s management team will host an earnings conference call at 8:00 AM on Wednesday, August 25, 2021, U.S. Eastern Time (8:00 PM on August 25, 2021, Beijing/Hong Kong Time). Please register in advance for the conference using the link provided below and dial in 10 minutes before the conference is scheduled to begin. Conference access information will be provided upon registration. Participant Online Registration:...

Continue reading

Live Ventures Announces Third Quarter Fiscal 2021 Financial Results

Company reports quarterly revenue of $69 million and net income attributable to common stock of $10 million LAS VEGAS, Aug. 16, 2021 (GLOBE NEWSWIRE) — Live Ventures Incorporated (Nasdaq: LIVE), a diversified holding company, today announced financial results for its third fiscal quarter ended June 30, 2021. The company reported revenues of $69.1 million, and basic earnings per share (“EPS”) of $6.35, which represents an increase of 63% and 191%, respectively, over the same quarter last year. The company also reported net income attributable to Live Ventures’ stockholders of $9.9 million, and operating income of $8.2 million, representing an increase of 177% and 37%, respectively, over the same period last year.    During the three months ended June 30,      2021   2020   % Change  Revenues   $ 69,095   $ 42,472   63 %Operating...

Continue reading

BioCorRx Provides Business Update for the Second Quarter of 2021

ANAHEIM, CA, Aug. 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use disorders, today provided a business update for the second quarter ended June 30, 2021 and reported on recent corporate developments.  Lourdes Felix, CEO, CFO and Director of BioCorRx Inc., stated, “During the quarter, we achieved a major milestone by receiving clearance from the U.S. Food and Drug Administration (FDA) to proceed to human trials for BICX104, a gradual release implantable pellet for opioid use disorder (OUD) being developed under the Company’s controlled subsidiary, BioCorRx Pharmaceuticals, Inc. The first in-human clinical trial will assess longevity, safety and tolerability of BICX104. Based on our previous pre-IND meeting...

Continue reading

Micron Solutions, Inc. Reports 2021 Second Quarter Results

FITCHBURG, Mass., Aug. 16, 2021 (GLOBE NEWSWIRE) — Micron Solutions, Inc. (OTCQB: MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, Inc., producing highly-engineered, innovative components requiring precision machining and injection molding, announced results for its second quarter ended June 30, 2021. In the second quarter of 2021, the Company reported $5,389,735 in revenue, as compared to $4,355,769 in the second quarter of 2020, a 23.7% increase. Net Income for the second quarter of 2021 was $3,012,602 compared to net income of $1,030,968 in the second quarter of 2020. Gross Margin decreased to 8.1% in the second quarter of 2021, compared to 15.6% in the second quarter of 2020. During the second quarter of 2021, the Company recognized a gain of $3,424,215...

Continue reading

HiberCell Expands Translational Oncology Toolbox by Acquiring Genuity Science, Inc.

Deal strengthens HiberCell’s balance sheet, accelerates clinical programs and expands pre-clinical pipeline through the integration of next generation artificial intelligence (AI) and machine learning (ML) strategies NEW YORK and BOSTON, Aug. 16, 2021 (GLOBE NEWSWIRE) — HiberCell, a clinical stage biotechnology company developing therapeutics to treat cancer relapse and metastasis, announced today the acquisition of Genuity Science, Inc., a life science technology company that provides world-leading genomics and multi-omic analytics bolstered by an advanced artificial intelligence (AI) and machine learning (ML) platform to illuminate the underlying cause of cancer and other diseases. Together, the combined company will strategically apply AI/ML to accelerate and advance its pipeline with a focus on overcoming the foundational barriers...

Continue reading

Buckeye Partners Acquires 270 MW Solar Project From OCI Solar Power

HOUSTON and SAN ANTONIO, Aug. 16, 2021 (GLOBE NEWSWIRE) — Buckeye Partners, L.P. (“Buckeye”) and OCI Solar Power, LLC (“OCI Solar Power”) announced today that Buckeye has acquired a 270 MW, construction-ready solar project (“Project Parker”) from OCI Solar Power. Project Parker includes two sites that are located on adjacent land in Falls County, Texas. OCI Solar Power has secured site control and completed all permitting and electrical interconnection agreements. Buckeye plans to start project design and construction later this year with the goal of bringing the project online in first quarter 2023. “Buckeye’s investment in Project Parker is an example of our strategy to drive sustainable value for our customers while playing an essential role in the energy transition,” said Buckeye President and CEO Clark Smith. “As we continue...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.